All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells

Journal of Cell Science

Volumn 121, Issue 19, 2008, Pages 3207-3217

  Tao, Rong Hua ^a   Maruyama, Ichi N ^a  

^a OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY GRADUATE UNIVERSITY   (Japan)

Author keywords

Cancer; Dimerization; Epidermal growth factor receptor; ErbB; Molecular mechanism; Transmembrane signal transduction

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; HETERODIMER; HOMODIMER;

ANIMAL CELL; ARTICLE; CANCER CHEMOTHERAPY; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIMERIZATION; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; CELL NUCLEUS; CELL SURVIVAL; CHO CELLS; CRICETINAE; CRICETULUS; ENDOPLASMIC RETICULUM; FLUORESCENCE; HUMANS; INTRACELLULAR SPACE; LIGANDS; MICE; MODELS, BIOLOGICAL; NIH 3T3 CELLS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SUBCELLULAR FRACTIONS;

MAMMALIA;

EID: 55449102296     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.033399     Document Type: Article

References (70)

1. Berger, M. B., Mendrola, J. M. and Lemmon, M. A. (2004). ErbB3/ HER3 does not homodimerize upon neuregulin binding at the cell surface. FEBS Lett. 569, 332-336.
2. Blondel, M., Bach, S., Bamps, S., Dobbelaere, J., Wiget, P., Longaretti, C., Barral, Y., Meijer, L. and Peter, M. (2005). Degradation of Hof1 by SCF(Grr1) is important for actomyosin contraction during cytokinesis in yeast. EMBO J. 24, 1440-1452.
3. Bouyain, S., Longo, P. A., Li, S., Ferguson, K. M. and Leahy, D. J. (2005). The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand. Proc. Natl. Acad. Sci. USA 102, 15024-15029.
4. Bublil, E. M. and Yarden, Y. (2007). The EGF receptor family: spearheading a merger of signaling and therapeutics. Curr. Opin. Cell Biol. 19, 124-134.
5. Burgess, A. W., Cho, H. S., Eigenbrot, C., Ferguson, K. M., Garret, T. P., Leahy, D. J., Lemmon, M. A., Sliwkowski, M. X., Ward, C. W. and Yokoyama, S. (2003). An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Mol. Cell 12, 541-552.
6. Cho, H.-S. and Leahy, D. J. (2002). Structure of the extracellular region of HER3 reveals an interdomain tether. Science 297, 1330-1333.
7. Cho, H.-S., Mason, K., Ramyar, K. X., Stanley, A. M., Gabelli, S. B., Denney, D. W., Jr and Leahy, D. J. (2003). Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 421, 756-760.
8. Citri, A. and Yarden, Y. (2006). EGF-ERBB signaling: towards the systems level. Nat. Rew. Mol. Cell. Biol. 7, 505-516.
9. Clayton, A. H. A., Walker, F., Ochard, S. G., Henderson, C., Fuchs, D., Rothacker, J., Nice, E. C. and Burgess, A. W. (2005). Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-a multidimensional microscopy analysis. J. Biol. Chem. 280, 30392-30399.
10. Dang, C. V., Barrett, J., Villa-Garcia, M., Resar, L. M. S., Kato, G. J. and Fearon, E. R. (1991). Intracellular leucine zipper interactions suggest c-Myc hetero-oligomerization. Mol. Cell. Biol. 11, 954-962.
11. Dawson, J. P., Berger, M. B., Lin, C. C., Schlessinger, J., Lemmon, M. A. and Ferguson, K. M. (2005). Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface. Mol. Cell. Biol. 25, 7734-7742.
12. Deppmann, C. D., Thornton, T. M., Utama, F. E. and Taparowsky, E. J. (2003). Phosphorylation of BATF regulates DNA binding: a novel mechanism for AP-1 (activator protein-1) regulation. Biochem. J. 374, 423-431.
13. Ferguson, K. M., Berger, M. B., Mendrola, J. M., Cho, H.-S., Leahy, D. J. and Lemmon, M. A. (2003). EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol. Cell 11, 507-517.
14. Fujiwara, T., Oda, K., Yokota, S., Takatsuki, A. and Ikehara, Y. (1988). Brefeldin A causes disassembly of Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum. J. Biol. Chem. 263, 18545-18552.
15. Furuuchi, K., Berezov, A., Kumagai, T. and Greene, M. I. (2007). Targeted antireceptor therapy with monoclonal antibodies leads to the formation of inactivated tetrameric forms of ErbB receptors. J. Immunol. 178, 1021-1029.
16. Gadella, T. W. J., Jr and Jovin, T. M. (1995). Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase recaptor activation. J. Cell Biol. 129, 1543-1558.
17. Gambarotta, G., Garzotto, D., Destro, E., Mautino, B., Giampietro, C., Cutrupi, S., Dati, C., Cattaneo, E., Fasolo, A. and Perroteau, I. (2004). ErbB4 expression in neural progenitor cells (ST14A) is necessary to mediate neuregulin-1β1-induced migration. J. Biol. Chem. 279, 48808-48816.
18. Garrett, T. P., McKern, N. M., Lou, M., Elleman, T. C., Adams, T. E., Lovrecz, G. O., Zhu, H. J., Walker, F., Frenkel, M. J., Hoyne, P. A. et al. (2002). Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha. Cell 110, 763-773.
19. Garrett, T. P., McKern, N. M., Lou, M., Elleman, T. C., Adams, T. E., Lovreez, G. O., Kofler, M., Jorissen, R. N., Nice, E. C., Burgess, A. W. et al. (2003). The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. Mol. Cell 11, 495-505.
20. Gent, J., van Kerkhof, P., Roza, M., Bu, G. and Strous, G. J. (2002). Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis. Proc. Natl. Acad Sci. USA 99, 9858-9863.
21. Ghosh, I., Hamilton, A. D. and Regan, L. (2000). Antiparallel leucine zipper-directed protein reassembly: application to the green fluorescent protein. J. Am. Chem. Soc. 122, 5658-5659.
22. Giese, B., Roderburg, C., Sommerauer, M., Wortmann, S. B., Metz, S., Heinrich, P. C. and Müller-Newen, G. (2005). Dimerization of the cytokine receptors gp130 and LIFR analysed in single cells. J. Cell Sci. 118, 5129-5140.
23. Giri, D. K., Ali-Seyed, M., Li, L. Y., Lee, D. F., Ling, P., Bartholomeusz, G., Wang, S. C. and Hung, M. C. (2005). Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor. Mol. Cell. Biol. 25, 11005-11018.
24. Hu, C. D., Chinenov, Y. and Kerppola, T. K. (2002). Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol. Cell 9, 789-798.
25. Huang, G. C., Ouyang, X. and Epstein, R. J. (1998). Proxy activation of protein ErbB2 by beterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction. Bioehem. J. 331, 113-119.
26. Hubbard, S. R. and Miller, W. T. (2007). Receptor tyrosine kinases: mechanisms of activation and signaling. Curr. Opin. Cell Biol. 19, 117-123.
27. Hunter, T. (2000). Signaling-2000 and beyond. Cell 100, 113-127.
28. Hynes, T. R., Tang, L., Mervine, S. M., Sabo, J. L., Yost, E. A., Devreotes, P. N. and Berlot, C. H. (2004). Visualization of G protein βγ dimers using bimolecular fluorescence complementation demonstrates roles for both β and γ in subcellular targeting. J. Biol. Chem. 279, 30279-30286.
29. Jorissen, R. N., Walker, F., Pouliot, N., Garrett, T. P. J., Ward, C. W. and Burgess, A. W. (2003). Epidermal growth factor receptor: mechanisms of activation and signaling. Exp. Cell Res. 284, 31-53.
30. Junttila, T. T., Sundvall, M., Määttä, J. A. and Elenius, K. (2000). Erbb4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants. Trends Cardiovasc. Med. 10, 304-310.
31. Kerppola, T. K. (2006). Visualization of molecular interactions by fluorescence complementation. Nat. Rev. Mol. Cell. Biol. 7, 449-456.
32. Koumakpayi, I. H., Diallo, J. S., Le Page, C., Lessard, L., Gleave, M., Bégin, L. R., Mes-Masson, A. M. and Saad, F. (2006). Expression and nuclear localization of ErbB3 in prostate cancer. Clin. Cancer Res. 12, 2730-2737.
33. c-neu and the epidermal growth factor receptor in ligand-independent association and transactivation. Proc. Natl. Acad. Sci. USA 100, 9220-9225.
34. Landau, M., Fleishman, S. J. and Ben-Tal, N. (2004). A putative mechanism for downregulation of the catalytic activity of the EGF receptor via direct contact between its kinase and C-terminal domains. Structure 12, 2265-2275.
35. Lin, S. Y., Makino, K., Xia, W., Matin, A., Wen, Y., Kwong, K. Y., Bourguignon, L. and Hung, M. C. (2001). Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat. Cell Biol. 3, 802-808.
36. Linggi, B. and Carpenter, G. (2006a). ErbB receptors: new insights on mechanisms and biology. Trends Cell Biol. 16, 649-656.
37. Linggi, B. and Carpenter, G. (2006b). ErbB-4 s80 intracellular domain abrogates ETO2-dependent transcriptional repression. J. Biol. Chem. 281, 25373-25380.
38. Liu, P., Sudhaharan, T., Koh, R. M. L., Hwang, L. C., Ahmed, S., Maruyama, I. N. and Wohland, T. (2007). Investigation of the dimerization of proteins from the epidermal growth factor receptor family by single wavelength fluorescence cross-correlation spectroscopy. Biophys. J. 93, 684-698.
39. Martin-Fernandez, M., Clarke, D. T., Tobin, M. J., Jones, S. V. and Jones, G. R. (2002). Preformed oligomeric epidermal growth factor receptors undergo an ectodomain structure change during signaling. Biophys. J. 82, 2415-2427.
40. Mendrola, J. M., Berger, M. B., King, M. C. and Lemmon, M. A. (2002). The single transmembrane domains of ErbB receptors self-associate in cell membranes. J. Biol. Chem. 277, 4704-4712.
41. Miaczynska, M., Pelkmans, L. and Zerial, M. (2004). Not just a sink: endosomes in control of signal transduction. Curr. Opin. Cell Biol. 16, 400-406.
42. Moriki, T., Maruyama, H. and Maruyama, I. N. (2001). Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J. Mol. Biol. 311, 1011-1026.
43. Nagai, T., Ibata, K., Park, E. S., Kubota, M., Mikoshiba, K. and Miyawaki, A. (2002). A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotech. 20, 87-90.
44. Ni, C. Y., Murphy, M. P., Golde, T. E. and Carpenter, G. (2001). γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294, 2179-2181.
45. Offterdinger, M., Schöfer, C., Weipoltshammer, K. and Grunt, T. W. (2002). c-erbB-3: a nuclear protein in mammary epithelial cells. J. Cell Biol. 157, 929-939.
46. Ogiso, H., Ishitani, R., Nureki O., Fukai S., Yamanaka, M., Kim, J. H., Saito, K., Sakamoto, A., Inoue, M., Shirouzu, M. et al. (2002). Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110, 775-787.
47. Olayioye, M. A., Neve, R. M., Lane, H. A. and Hynes, N. E. (2000). The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 19, 3159-3167.
48. Pawson, T. (2004). Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell 116, 191-203.
49. Penuel, E., Akita, R. W. and Sliwkowski, M. X. (2002). Identification of a region within the ErbB2/HER2 intracellular domain that is necessary for ligand-independent association. J. Biol. Chem. 277, 28468-28473.
50. Schlessinger, J. (2000). Cell signaling by receptor tyrosine kinases. Cell 103, 211-225.
51. Schlessinger, J. (2002). Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 110, 669-672.
52. Shyu, Y. J., Liu, H., Deng, X. and Hu, C. D. (2006). Identification of new fluorescent protein fragments for bimolecular fluorescence complementation analysis under physiological conditions. Biotechniques 40, 61-66.
53. Smith, S. O., Smith, C., Shekar, S., Peersen, O., Ziliox, M. and Aimoto, S. (2002). Transmembrane interactions in the activation of the Neu receptor tyrosine kinase. Biochemistry 41, 9321-9332.
54. Sorkin, A. and Von Zastrow, M. (2002). Signal transduction and endocytosis: close encounters of many kinds. Nat. Rev. Mol. Cell. Biol. 3, 600-614.
55. Stamos. J., Sliwkowski, M. X. and Eigenbrot, C. (2002). Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J. Biol. Chem. 277, 46265-46272.
56. Sundvall, M., Peri, L., Määttä, J. A., Tvorogov, D., Paatero, I., Savisalo, M., Silvennoinen, O., Yarden, Y. and Elenius, K. (2007). Differential nuclear localization and kinase activity of alternative ErbB4 intracellular domains. Oncogene 26, 6905-6914.
57. Tamura, G., Ando, K., Suzuki, S., Takatsuki, A. and Arima, K. (1968). Antiviral activity of brefeldin A and venucarin A. J. Antibiotics 21, 160-161.
58. Tao, R. H., Kawate, H., Wu, Y., Ohnaka, K., Ishizuka, M., Inoue, A., Hagiwara, H. and Takayanagi, R. (2006). Testicular zinc finger protein recruits historic deacetylase 2 and suppresses the transactivation function and intranuclear foci formation of agonist-bound androgen receptor competitively with TIF2. Mol. Cell. Endocrinol. 247, 150-165.
59. Teramura, Y., Ichinose, J., Takagi, H., Nishida, K., Yanagida, T. and Sako, Y. (2006). Single-molecule analysis of epidermal growth factor binding on the surface of living cells. EMBO J. 25, 4215-4222.
60. Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Levi, S., Ratzkin, B. J. and Yarden, Y. (1996). A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor. Mol. Cell. Biol. 16, 5276-5287.
61. Ullrich, A., Coussens, L., Hayflick, J. S., Dull, T. J., Gray, A., Tam, A. W., Lee, J., Yarden, Y., Libermann, T. A., Schlessinger, J. et al. (1984). Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309, 418-425.
62. Wang, S. C., Lien, H. C., Xia, W., Chen, I. F., Lo, H. W., Wang, Z., All-Seyed, M., Lee, D. F., Bartholomeusz, G., Ou-Yang, F. et al. (2004). Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 6, 251-261.
63. Warren, C. M. and Landgraf, R. (2006). Signaling through ERBB receptors: Multiple layers of diversity and control. Cell. Signal. 18, 923-933.
64. Whitson, K. B., Beechem, J. M., Beth, A. H. and Staros, J. V. (2004). Preparation and characterization of Alexa Fluor 594-labeled epidermal growth factor for fluorescence resonance energy transfer studies: application to the epidermal growth factor receptor. Anal. Biochem. 324, 227-236.
65. Williams, C. C.9 Allison, J. G., Vidal, G. A., Burow, M. E., Beckman, B. S., Marrero, L. and Jones. F. E. (2004). The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J. Cell Biol. 167, 469-478.
66. Yarden, Y. and Sliwkowski, M. X. (2001). Untangling the ErbB signalling network. Nat. Rev. Mol. Cell. Biol. 2, 127-137.
67. Yu, X., Sharma, K. D., Takahashi, T., Iwamoto, R. and Mekada, E. (2002). Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling. Mol. Biol. Cell 13, 2547-2557.
68. Zhang, S., Ma, C. and Chalfie, M. (2004). Combinatorial marking of cells and organelles with reconstituted fluorescent proteins. Cell 119, 137-144.
69. Zhang, X., Gureasko, J., Shen, K., Cole, P. A. and Kuriyan, J. (2006). An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125, 1137-1149.
70. Zuria, A. R., Crespo, P. M., Koritschoner, N. P. and Daniotti, J. L. (2004). Membrane distribution of epidermal growth factor receptors in cells expressing different angliosides. Eur. J. Biochem. 271, 2428-2437.